These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1796180)

  • 1. Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa.
    Harty RF; Pearson PH; Solomon TE; McGuigan JE
    Regul Pept; 1991 Oct; 36(1):141-50. PubMed ID: 1796180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meal-related cholecystokinin secretion in eating and affective disorders.
    Geracioti TD; Kling MA; Joseph-Vanderpool JR; Kanayama S; Rosenthal NE; Gold PW; Liddle RA
    Psychopharmacol Bull; 1989; 25(3):444-9. PubMed ID: 2697014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy.
    Tamai H; Takemura J; Kobayashi N; Matsubayashi S; Matsukura S; Nakagawa T
    Metabolism; 1993 May; 42(5):581-4. PubMed ID: 8492713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
    Yaksh TL; Abay EO; Go VL
    Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed cholecystokinin secretion in patients with eating disorders.
    Phillipp E; Pirke KM; Kellner MB; Krieg JC
    Life Sci; 1991; 48(25):2443-50. PubMed ID: 2046469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cosecretion of peptide histidine methionine (PHM) and vasoactive intestinal peptide (VIP) in patients with VIP-producing tumors.
    Fahrenkrug J; Pedersen JH
    Peptides; 1986; 7(5):717-21. PubMed ID: 3797338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging.
    MacIntosh CG; Morley JE; Wishart J; Morris H; Jansen JB; Horowitz M; Chapman IM
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5830-7. PubMed ID: 11739447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entero-insular axis in children with anorexia nervosa.
    Tomasik PJ; Sztefko K; Starzyk J; Rogatko I; Szafran Z
    Psychoneuroendocrinology; 2005 May; 30(4):364-72. PubMed ID: 15694116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity.
    Baranowska B; Radzikowska M; Wasilewska-Dziubinska E; Roguski K; Borowiec M
    Diabetes Obes Metab; 2000 Apr; 2(2):99-103. PubMed ID: 11220530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCK response in bulimia nervosa and following remission.
    Hannon-Engel SL; Filin EE; Wolfe BE
    Physiol Behav; 2013 Oct; 122():56-61. PubMed ID: 23988345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.
    Hang CH; Shi JX; Li JS; Wu W; Li WQ; Yin HX
    World J Gastroenterol; 2004 Mar; 10(6):875-80. PubMed ID: 15040036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional observations on cholecystokinin and the vasoactive intestinal polypeptide.
    Mutt V
    Peptides; 1981; 2 Suppl 2():209-14. PubMed ID: 6283492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution, plasma concentration, and in vivo prolactin-releasing activity of peptide histidine methionine in humans.
    Sasaki A; Sato S; Go MG; Shimizu Y; Murakami O; Hanew K; Yumita S; Andoh N; Sasano N; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Oct; 65(4):683-8. PubMed ID: 3654914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin revisited: CCK and the hunger trap in anorexia nervosa.
    Cuntz U; Enck P; Frühauf E; Lehnert P; Riepl RL; Fichter MM; Otto B
    PLoS One; 2013; 8(1):e54457. PubMed ID: 23349895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori.
    Konturek JW; Konturek SJ; Kwiecień N; Bielański W; Pawlik T; Rembiasz K; Domschke W
    Scand J Gastroenterol; 2001 Nov; 36(11):1148-54. PubMed ID: 11686213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma cholecystokinin response following ingestion of test meal by patients with non-insulin dependent diabetes mellitus.
    Nakano I; Funakoshi A; Shinozaki H; Miyazaki K; Ibayashi H; Tateishi K; Hamaoka T
    Regul Pept; 1986 May; 14(3):229-36. PubMed ID: 3726174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric release of vasoactive intestinal peptide after a peptone meal in the dog.
    Wolfe MM; Misbin RI; Gardner DF; McGuigan JE
    Regul Pept; 1983 Jan; 5(2):103-9. PubMed ID: 6828775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
    Watanobe H; Tamura T; Takahashi K
    Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.